Table II.
Characteristic | Value (mean ± SD) |
---|---|
Total no. of participants | 7 |
Age, y | 43.29±7.95 |
Gender, female, % | 6 (85.7%) |
TBIL, µmol/l | 11.40±4.47 |
DBIL, µmol/l | 3.09±1.68 |
Albumin, g/l | 44.67±4.51 |
Hemoglobin, g/l | 128.14±4.98 |
ALT, U/l | 18.86±15.26 |
AST, U/l | 19.57±6.19 |
AFP, µg/l | 3.06±2.03 |
CEA, µg/l | 1.24±0.30 |
CA19-9, U/ml | 13.14±7.99 |
Viral hepatitis, positive, % | 1 (14.28%) |
Data are presented as the mean ± SD or n (%). SD, standard deviation; TBIL, total bilirubin; DBIL, direct bilirubin; ALT, alanine transaminase; AST, aspartate transaminase; AFP, α-fetoprotein; CEA, carcinoembryonic antigen; CA19-9, cancer antigen 19-9.